The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Cited by (1,044)

Items 1,001–1,044 of 1,044

1. Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension
   Karns, Adam D., Bral, Jacqueline M., Hartman, Daniel, Peppard, Thomas, Schumacher, Christoph · 2013 · The Journal of Clinical Hypertension
2. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure
   Arutyunov, Gregory P., Kostyukevich, Olga I., Serov, Roman A., Rylova, Natalya V., Bylova, Nadezda A. · 2008 · International Journal of Cardiology
3. Low renal mineralocorticoid receptor expression at birth contributes to partial aldosterone resistance in neonates
   Martinerie, Laetitia, Viengchareun, Say, Delezoide, Anne-Lise, Jaubert, Francis, Sinico, Martine, Prevot, Sophie, Boileau, Pascal, Meduri, Geri, Lombès, Marc · 2009 · Endocrinology
4. The renin–angiotensin–aldosterone system and calcium-regulatory hormones
   Vaidya, A, Brown, J M, Williams, J S · 2015 · Journal of Human Hypertension
5. Role of aldosterone and angiotensin II in insulin resistance: an update
   Lastra‐Lastra, Guido, Sowers, James R., Restrepo‐Erazo, Katherine, Manrique‐Acevedo, Camila, Lastra‐González, Guido · 2009 · Clinical Endocrinology
6. Apparent mineralocorticoid excess
   Funder, John W. · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
7. Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone
   Brown, Jenifer M., Williams, Jonathan S., Luther, James M., Garg, Rajesh, Garza, Amanda E., Pojoga, Luminita H., Ruan, Daniel T., Williams, Gordon H., Adler, Gail K., Vaidya, Anand · 2014 · Hypertension
8. A Look Between the Cardiomyocytes: The Extracellular Matrix in Heart Failure
   Miner, Edward C., Miller, Wayne L. · 2006 · Mayo Clinic Proceedings
9. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism
   Sartorato, Paola, Lapeyraque, Anne-Laure, Armanini, Decio, Kuhnle, Ursula, Khaldi, Yasmina, Salomon, Rémi, Abadie, Véronique, Di Battista, Eliana, Naselli, Arturo, Racine, Alain et al. · 2003 · The Journal of Clinical Endocrinology & Metabolism
10. Estrogen Reduces Aldosterone, Upregulates Adrenal Angiotensin II AT<sub>2</sub> Receptors and Normalizes Adrenomedullary Fra-2 in Ovariectomized Rats
    Macova, Miroslava, Armando, Ines, Zhou, Jin, Baiardi, Gustavo, Tyurmin, Dmitri, Larrayoz-Roldan, Ignacio M., Saavedra, Juan M. · 2008 · Neuroendocrinology
11. The Role of Aldosteronism in Causing Obesity-Related Cardiovascular Risk
    Calhoun, David A., Sharma, Kumar · 2010 · Cardiology Clinics
12. Aldosterone, Parathyroid Hormone, and the Use of Renin-Angiotensin-Aldosterone System Inhibitors: The Multi-Ethnic Study of Atherosclerosis
    Brown, Jenifer, de Boer, Ian H., Robinson-Cohen, Cassianne, Siscovick, David S., Kestenbaum, Bryan, Allison, Matthew, Vaidya, Anand · 2015 · The Journal of Clinical Endocrinology & Metabolism
13. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists
    Collins, P., Rosano, G., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T., Palacios, S., Preston, R. et al. · 2007 · Climacteric
14. Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: A multicenter, randomized clinical trial
    Kato, Sawako, Maruyama, Shoichi, Makino, Hirofumi, Wada, Jun, Ogawa, Daisuke, Uzu, Takashi, Araki, Hisazumi, Koya, Daisuke, Kanasaki, Keizo, Oiso, Yutaka et al. · 2015 · Clinical and Experimental Nephrology
15. Expression and roles of steroidogenic acute regulatory (StAR) protein in 'non-classical', extra-adrenal and extra-gonadal cells and tissues
    Anuka, Eli, Gal, Michael, Stocco, Douglas M., Orly, Joseph · 2013 · Molecular and Cellular Endocrinology
16. Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion
    Schmidt, K., Tissier, R., Ghaleh, B., Drogies, T., Felix, S. B., Krieg, T. · 2010 · European Heart Journal
17. Hypertension Canada guideline for the diagnosis and treatment of hypertension in adults in primary care
    Goupil, Rémi, Tsuyuki, Ross T., Santesso, Nancy, Terenzi, Kristin A., Habert, Jeffrey, Cheng, Gemma, Gysel, Stephanie C., Bruneau, Jill, Leung, Alexander A., Campbell, Norman R.C. et al. · 2025 · Canadian Medical Association Journal
18. Spironolactone in the treatment of polycystic ovary syndrome
    Armanini, Decio, Andrisani, Alessandra, Bordin, Luciana, Sabbadin, Chiara · 2016 · Expert Opinion on Pharmacotherapy
19. Community Care in England: Reducing Socioeconomic Inequalities in Heart Failure
    Hawkins, Nathaniel M., Scholes, Shaun, Bajekal, Madhavi, Love, Hande, O'Flaherty, Martin, Raine, Rosalind, Capewell, Simon · 2012 · Circulation
20. Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis
    Samnani, Sunil, Cenzer, Irena, Kline, Gregory A, Lee, Sei J, Hundemer, Gregory L, McClurg, Caitlin, Pasieka, Janice L, Boscardin, W John, Ronksley, Paul E, Leung, Alexander A · 2024 · The Journal of Clinical Endocrinology & Metabolism
21. Declining public health burden of digoxin toxicity from 1991 to 2004
    Haynes, K, Heitjan, DF, Kanetsky, PA, Hennessy, S · 2008 · Clinical Pharmacology & Therapeutics
22. Mineralocorticoid receptors modulate vascular endothelial function in human obesity
    Hwang, Moon-Hyon, Yoo, Jeung-Ki, Luttrell, Meredith, Kim, Han-Kyul, Meade, Thomas H., English, Mark, Segal, Mark S., Christou, Demetra D. · 2013 · Clinical Science
23. Aldosterone: A cardiovascular risk factor?
    Funder, John W., Reincke, Martin · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
24. Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases
    Médeau, Virginie, Moreau, François, Trinquart, Ludovic, Clemessy, Maud, Wémeau, Jean‐Louis, Vantyghem, Marie Christine, Plouin, Pierre‐François, Reznik, Yves · 2008 · Clinical Endocrinology
25. Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone
    Armanini, Decio, Bordin, Luciana, Donà, Gabriella, Sabbadin, Chiara, Bakdounes, Leila, Ragazzi, Eugenio, Giorgino, Francesco L., Fiore, Cristina · 2012 · Steroids
26. Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
    Borne, Ryan T., Katz, David, Betz, Jarrod, Peterson, Pamela N., Masoudi, Frederick A. · 2017 · Journal of the American Heart Association
27. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure
    Shah, Nimit C, Pringle, Stuart D, Donnan, Peter T, Struthers, Allan D · 2007 · Journal of Hypertension
28. Basal–bolus insulin versus sliding‐scale insulin for inpatient glycaemic control: a clinical practice comparison
    Roberts, Greg W, Aguilar‐Loza, Norma, Esterman, Adrian, Burt, Morton G, Stranks, Stephen N · 2012 · Medical Journal of Australia
29. Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF
    Dewan, Pooja, Solomon, Scott D., Jhund, Pardeep S., Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Ponikowski, Piotr, DeMets, David L., Sabatine, Marc S. et al. · 2020 · European Journal of Heart Failure
30. Cardiovascular Protection With Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Chronic Kidney Disease: A Milestone Achieved
    Sarafidis, Pantelis, Papadopoulos, Christodoulos E., Kamperidis, Vasilios, Giannakoulas, George, Doumas, Michael · 2021 · Hypertension
31. Interactions between adrenal-regulatory and calcium-regulatory hormones in human health
    Brown, Jenifer M., Vaidya, Anand · 2014 · Current Opinion in Endocrinology, Diabetes & Obesity
32. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis
    Catalá-López, Ferrán, Aleixandre-Benavent, Rafael, Caulley, Lisa, Hutton, Brian, Tabarés-Seisdedos, Rafael, Moher, David, Alonso-Arroyo, Adolfo · 2020 · Trials
33. Dilated Cardiomyopathy: From Genetics to Clinical Management
    2019
34. QT interval in patients with primary aldosteronism and low-renin essential hypertension
    Maule, Simona, Mulatero, Paolo, Milan, Alberto, Leotta, Giannina, Caserta, Mimma, Bertello, Chiara, Rabbia, Franco, Veglio, Franco · 2006 · Journal of Hypertension
35. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment
    Hundemer, Gregory L. · 2019 · Current Cardiology Reports
36. Observational cohort study of the safety of digoxin use in women with heart failure
    Flory, James H, Ky, Bonnie, Haynes, Kevin, M Brunelli, Steve, Munson, Jeffrey, Rowan, Christopher, Strom, Brian L, Hennessy, Sean · 2012 · BMJ Open
37. Aldosterone in gynecology and its involvement on the risk of hypertension in pregnancy
    Sabbadin, Chiara, Andrisani, Alessandra, Ambrosini, Guido, Bordin, Luciana, Donà, Gabriella, Manso, Jacopo, Ceccato, Filippo, Scaroni, Carla, Armanini, Decio · 2019 · Frontiers in Endocrinology
38. Continuation of chronic heart failure therapies during heart failure hospitalization—a review
    Singhania, Girish, Ejaz, Abutaleb A., McCullough, Peter A., Kluger, Aaron Y., Balamuthusamy, Saravanan, Dass, Bhagwan, Singhania, Namrata, Agarwal, Adhish · 2019 · Reviews in Cardiovascular Medicine
39. Hypoglycaemia increases aldosterone in a dose-dependent fashion
    Adler, G. K., Bonyhay, I., Curren, V., Waring, E., Freeman, R. · 2010 · Diabetic Medicine
40. Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
    Zaheer, Sarah, Brown, Jenifer M., Connors, Molly, Williams, Jonathan S., Adler, Gail K., Vaidya, Anand · 2017 · International Journal of Endocrinology
41. Aldosterone Synthase Inhibition in Hypertension
    Andersen, Karl · 2013 · Current Hypertension Reports
42. Impact of Smoking Reduction on Coronary Heart Disease Mortality Trends During 1981–2000 in England and Wales
    Unal, B, Critchley, JA, Capewell, S · 2003 · Tobacco Induced Diseases
43. Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
    Fernet, Mireille, Beckerman, Bruce, Abreu, Paula, Lins, Katharina, Vincent, John, Burgess, Ellen · 2018 · Vascular Health and Risk Management
44. Circulating aldosterone and mortality in female nursing home residents
    Tomaschitz, Andreas, Pilz, Stefan, Pieske, Burkert, Ritz, Eberhard, März, Winfried, Meinitzer, Andreas, Dobnig, Harald, Amrein, Karin, Kienreich, Katharina, Verheyen, Nicolas et al. · 2013 · Experimental Gerontology